Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Express Scripts
McKinsey
McKesson

Last Updated: February 2, 2023

Ingenus Pharms Llc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for INGENUS PHARMS LLC, and what generic alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has thirteen approved drugs.

There is one US patent protecting INGENUS PHARMS LLC drugs.

There is one patent family member on INGENUS PHARMS LLC drugs in one country and twenty-three supplementary protection certificates in nine countries.

Summary for Ingenus Pharms Llc
International Patents:1
US Patents:1
Tradenames:13
Ingredients:13
NDAs:13

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc TIMOLOL MALEATE timolol maleate SOLUTION/DROPS;OPHTHALMIC 216533-002 Sep 13, 2022 AT3 RX No No See Plans and Pricing See Plans and Pricing
Ingenus Pharms Llc PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 211368-001 Mar 1, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Ingenus Pharms Llc ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 208968-001 Feb 19, 2020 AP RX No No See Plans and Pricing See Plans and Pricing
Ingenus Pharms Llc CLOBETASOL PROPIONATE clobetasol propionate AEROSOL, FOAM;TOPICAL 206805-001 Jul 31, 2017 DISCN No No See Plans and Pricing See Plans and Pricing
Ingenus Pharms Llc CYCLOPHOSPHAMIDE cyclophosphamide SOLUTION;INTRAVENOUS 212501-001 Jul 30, 2020 RX Yes Yes 10,993,952 See Plans and Pricing Y See Plans and Pricing
Ingenus Pharms Llc IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 214051-002 Dec 30, 2021 DISCN No No See Plans and Pricing See Plans and Pricing
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-003 Aug 31, 2017 AP RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Ingenus Pharms Llc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2785706 122020000046 Germany See Plans and Pricing PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316
1667986 92172 Luxembourg See Plans and Pricing PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
0509752 49/1999 Austria See Plans and Pricing PRODUCT NAME: DORZOLAMID ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE DORZOLAMIDHYDROCHLORID, UND TIMOLOL ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE TIMOLOLMALEAT; NAT. REGISTRATION NO/DATE: 1-22701, 1-22702 19980828; FIRST REGISTRATION: DK 9794 19980306
0260415 C990036 Netherlands See Plans and Pricing PRODUCT NAME: CARMUSTINE; NAT. REGISTRATION NO/DATE: RVG 24056 19990809; FIRST REGISTRATION: FR 561 907-5 19981210
0166287 SPC/GB96/056 United Kingdom See Plans and Pricing PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604
2785706 2020C/516 Belgium See Plans and Pricing PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318
0509752 2000C/001 Belgium See Plans and Pricing PRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
McKesson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.